Font Size: a A A
Keyword [Dual antiplatelet]
Result: 81 - 100 | Page: 5 of 6
81. Clinical Analysis Of Upper Gastrointestinal Tract Injury Associated With Dual Antiplatelet Therapy After Percutaneous Coronary Intervention(PCI)
82. Duration Of Dual Antiplatelet Therapy After Second-genenration Drug-eluting Stent Implantation In Patients With Diabetes Mellitus
83. Comparing Dual Vs. Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation
84. Impact Of 13C-urea Breath Test On Upper Gastrointestinal Bleeding Associated With Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
85. Clinical Analysis Of Dual Antiplatelet Therapy For Acute Cerebral Infarction
86. Clinical Outcomes Of Aspirin Combined With Clopidogrel In Treatment Of Minor Noncardioembolic Ischemic Stroke(NIHSS ?5)
87. Analysis On The Current Status And Causes Of Dual Anti-platelet Therapy For SICAS Patients In Hospital Based On Big Data Platform Of Chronic Disease Management
88. Meta-analysis Of The Effectiveness And Safety Of Short-term(1-3 Month) Vs Standard(12 Month) Dual Antiplatelet Therapy After New Generation Drug-eluting Stents Implantion
89. Clinical Outcomes Of Very Short Term Dual Antiplatelet Therapy In Patients With Or Without Diabetes Undergoing Second-generation Drug-eluting Stents: A Meta-analysis
90. Effects Of Different Antiplatelet Therapies On Prognosis Of Patients With Acute Coronary Syndrome And Moderate Baseline Thrombocytopenia
91. Efficacy And Safety Of Dual Antiplatelet Therapy After Percutaneous Coronary Drug-eluting Stenting:A Network Meta-analysis
92. A Markov Pattern Analysis About Three Kinds Of Dual Antiplatelet Therapy
93. Study On Antiplatelet Efficacy And Its Effect On Recent Adverse Events Of Pre-PCI Dual Antiplatelet Therapy With Different Durations In Chinese Elderly Patients With ACS
94. Correlation Study Of Antiplatelet Drug Gene Polymorphism With Platelet Aggregation Rate And Thrombotic Events After PCI
95. Meta Analysis Of Short-term Dual Antiplatelet Therapy After PCI
96. Meta Analysis Of Dual Antiplatelet Therapy ?3 Months And Dual Antiplatelet Therapy 12-Months After Second-generation Drug-eluting Stents Implantation
97. Six-Versus Twelve-Month Dual Antiplatelet Therapy On Clinical Prognosis In Patients With High Bleeding Risk
98. Efficacy And Safety Of Short-term Versus Standard Dual Antiplatelet Therapy In Patients Undergoing Percutaneous Coronary Intervention: A Meta-analysis
99. Efficacy And Safety Of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
100. Efficacy And Safety Of Dual Antiplatelet Therapy Guided By Continuous Platelet Aggregation Rate Detection In Patients With Acute Coronary Syndrome
  <<First  <Prev  Next>  Last>>  Jump to